This webinar occurred on May 19, 2021
 

• Presentation Slides

• TelePain Overview Video

• Webinar Recording

• Newsletter Article - Celebrating Anniversaries of UW TelePain and Pain & Opioid Hotline

 

Join the Washington Medical Commission for an educational opportunity on Telehealth Delivered Multidisciplinary Pain Care. The webinar will cover:

• Pain management and opioid prescribing-based telehealth modalities into your clinical practice.
• Delineate specific telehealth attributes that support guideline compliant care for your challenging patients with chronic pain.
• Differentiate benefits of the Pain & Opioid Hotline compared with UW TelePain.
• Describe the value of “PainTracker” and how to access the mobile app for use by you and your patients at no-cost. 

Educational Objectives

Upon completion of this educational activity, participants should be able to:

• Apply pain management and opioid prescribing-based telehealth modalities into your clinical practice.
• Delineate specific telehealth attributes that support guideline compliant care for your challenging patients. 
• Describe the value of “PainTracker” and how to access the mobile app for use by you and your patients. 

Target Audience

This activity is designed to educate commission members, practitioners, medical regulatory staff, and the public.

---

Speaker Biographies

Jacob Gross M.D., M.P.H.

Dr. Gross is an Acting Assistant Professor in the Department of Anesthesiology and Pain Medicine at the University of Washington. He completed Residency in Anesthesiology and Pain Medicine fellowship at the University of Washington and currently serves as Director of Resident Education and Associate Program Director for the UW Pain Fellowship. He received his undergraduate degree from the University of Michigan and attended the University of Texas at Houston for his Medical and Public Health Degrees.

 

 

 

David Tauben, M.D., FACP

Dr. Tauben is Emeritus Clinical Professor in the Departments of Medicine and Anesthesia & Pain Medicine, and recently retired Chief of the UW Division of Pain Medicine, board certified in both Internal Medicine and Pain Medicine, and has practiced as Primary Care physician for 30 years and Pain Medicine expert for over 25 years. Dr. Tauben is also UW Director of Medical Student Education in Pain Medicine and leads UW TelePain, an innovative tele-video-conferencing program delivering pain and addiction management educational consultative support to Pacific Northwest primary care providers.  He has been principal investigator for the UW’s NIH Pain Consortium Center of Excellence for Pain Education, a member of the NIH National Pain Strategy task force on Pain Education, and a founding and continuing member of the State of Washington Agency Medical Directors panel of clinician experts developing opioid prescription guidelines for chronic pain. He earned his BA in Philosophy at Yale University, Medical Degree at Tufts University, and completed his Residency training at the University of Washington.

Dr Tauben’s Videos

• Implementing New Models for Expanding Access to Multidisciplinary Pain Care via Telehealth: Out-Patient Pain Management in the Midst of the Covid-19 Public Health Emergency
• Public Education: The Opioid Epidemic (Public lecture at Davenport Hotel, Spokane)
• International Recognition: Interview with David Tauben: Pain Management
• National Recognition: National Institutes of Health Pain Consortium Award 2013-present

Cara Towle

Cara Towle has more than 20 years of experience in telehealth. With a master’s degree in Nursing (University of California, San Francisco) and in International Educational Administration (School for International Training, VT), she established the UCSF International Medical Services in 1996, building clinical and educational telehealth programs reaching Asia, Europe, and the Middle East. From 2001 until 2015, she served as the founding Director for Telehealth Services at the University of Washington, creating a new rural telehealth network, delivering numerous programs and services across Washington and beyond. In 2016, she moved to the UW Psychiatry and Behavioral Sciences to develop innovative telepsychiatry services. She is a founding Board member and former Board Chair for the Northwest Regional Telehealth Resource Center, as well as a founding board member of the Washington State Telehealth Collaborative.

 

 

Mackenzie Welsh, PharmD
Mackenzie is a Clinical Pharmacist with specialized training in Pain Management and Palliative Care, employed at UW Medicine rotating through the Inpatient Chronic Pain Service, Inpatient Palliative Care Service, and Center for Pain Relief Clinic. She earned her BA in Health Sciences at Drake University, Pharmacy Degree at University of Iowa, and completed her Residency training at Scripps Mercy Hospital in San Diego, CA and University of Washington.

 

 

 

---

Continuing Medical Education

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Federation of State Medical Boards and the Washington Medical Commission. The Federation of State Medical Boards is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement

The Federation of State Medical Boards designates this internet enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Course Director

Alden Roberts, MD
Washington Medical Commission

Commercial Support

This learning activity is not funded by any commercial entity. 
However, the Washington Medical Commission gratefully acknowledges the unrestricted educational grant from the FSMB Foundation in the amount of  $10,000 to support this activity.

Disclosure of Commercial Interest

As an organization accredited by the ACCME, the Federation of State Medical Boards (FSMB) requires that the content of CME activities and related materials provide balance, independence, objectivity, and scientific rigor. Planning must be free of the influence or control of a commercial entity and promote improvements or quality in healthcare. All persons in the position to control the content of an education activity are required to disclose all relevant financial relationships in any amount occurring within the past 12 months with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on patients.

The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that create a conflict of interest. The FSMB has implemented a mechanism to identify and resolve all conflicts of interest prior to the activity. The intent of this policy is to identify potential conflicts of interest so participants can form their own judgments with full disclosure of the facts. Participants will be asked to evaluate whether the speaker’s outside interests reflect a possible bias in the planning or presentation of the activity. 

The speakers, course director and planners at the Federation of State Medical Boards and the Washington Medical Commission have no relevant financial interests to disclose.

Disclosure of Unlabeled Uses

This educational activity may contain discussion of published and/or investigational uses of agents that are not approved by the U.S. Food and Drug Administration. For additional information about approved uses, including approved indications, contraindications, and warnings, please refer to the prescribing information for each product, or consult the Physicians’ Desk Reference.

Faculty and Staff Disclosures

Name of Individual	Drugs/Products to be referenced
David Tauben, MD, FACP	Off label but widely studied and recommended non-opioid analgesics, possibly drugs such as buprenorphine (Suboxone) and antidepressants for chronic pain.

 

No speakers or persons in control of content reported intent to reference unlabeled/unapproved uses of drugs or products.